With a market cap of $74.3 billion, Irving, Texas-based McKesson Corporation (MCK) is a global healthcare services and ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

A unified and interoperable healthcare infrastructure is not just a technical milestone—it is a transformative step forward.

where the company provided patients with greater choice and access, integrated pharmacy care and enhanced service levels. McKesson Canada also owned and operated Well.ca, a Canadian online health ...

McKesson Corporation (NYSE: MCK) reported today that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch ...

Cardinal Health’s profit margin lags behind peers, impacting growth. See why CAH stock’s outlook may be hindered by legal ...

While medical device shortages are nothing new, the FDA said it is becoming more concerned that supply chain disruptions are ...

Technology often plays a critical role in strategies to combat rising costs while maintaining quality care. Here are four ...